{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:31:25Z","timestamp":1791973885183,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K20242"],"award-info":[{"award-number":["JP16K20242"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["JARO"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10162-019-00727-1","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T14:02:43Z","timestamp":1561730563000},"page":"449-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling"],"prefix":"10.1007","volume":"20","author":[{"given":"Ryusuke","family":"Imai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriko","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Morihana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzuyo","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Okuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"727_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/00016488409132918","volume":"97","author":"M Abramson","year":"1984","unstructured":"Abramson M, Moriyama H, Huang CC (1984) Pathogenic factors in bone resorption in cholesteatoma. Acta Otolaryngol 97:437\u2013442. \n                    https:\/\/doi.org\/10.3109\/00016488409132918","journal-title":"Acta Otolaryngol"},{"key":"727_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/187153006779025711","volume":"6","author":"J Akaogi","year":"2006","unstructured":"Akaogi J, Nozaki T, Satoh M, Yamada H (2006) Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy endocrine. Metab Immune Disord Drug Targets 6:383\u2013394. \n                    https:\/\/doi.org\/10.2174\/187153006779025711","journal-title":"Metab Immune Disord Drug Targets"},{"key":"727_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25\u201329. \n                    https:\/\/doi.org\/10.1038\/75556","journal-title":"Nat Genet"},{"key":"727_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342. \n                    https:\/\/doi.org\/10.1038\/nature01658","journal-title":"Nature"},{"key":"727_CR5","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::Aid-art15>3.0.Co;2-2","volume":"41","author":"B Bresnihan","year":"1998","unstructured":"Bresnihan B et al (1998) Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41:2196\u20132204. \n                    https:\/\/doi.org\/10.1002\/1529-0131(199812)41:12<2196::Aid-art15>3.0.Co;2-2","journal-title":"Arthritis Rheum"},{"key":"727_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3109\/00016489.2015.1011789","volume":"135","author":"AP Chen","year":"2015","unstructured":"Chen AP et al (2015) Expression levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin are associated with middle ear cholesteatoma risk. Acta Otolaryngol 135:655\u2013666. \n                    https:\/\/doi.org\/10.3109\/00016489.2015.1011789","journal-title":"Acta Otolaryngol"},{"key":"727_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/0140-6736(91)91902-7","volume":"338","author":"IM Cheshire","year":"1991","unstructured":"Cheshire IM, Blight A, Ratcliffe WA, Proops DW, Heath DA (1991) Production of parathyroid-hormone-related protein by cholesteatoma cells in culture. Lancet 338:1041\u20131043","journal-title":"Lancet"},{"key":"727_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-014-2275-0","volume":"400","author":"Z Chi","year":"2015","unstructured":"Chi Z, Wang Z, Liang Q, Zhu Y, du Q (2015) Induction of cytokine production in cholesteatoma keratinocytes by extracellular high-mobility group box chromosomal protein 1 combined with DNA released by apoptotic cholesteatoma keratinocytes. Mol Cell Biochem 400:189\u2013200. \n                    https:\/\/doi.org\/10.1007\/s11010-014-2275-0","journal-title":"Mol Cell Biochem"},{"key":"727_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/lary.5540940117","volume":"94","author":"RA Chole","year":"1984","unstructured":"Chole RA (1984) Cellular and subcellular events of bone resorption in human and experimental cholesteatoma: the role of osteoclasts. Laryngoscope 94:76\u201395","journal-title":"Laryngoscope"},{"key":"727_CR10","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/art.10623","volume":"46","author":"EH Choy","year":"2002","unstructured":"Choy EH et al (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 46:3143\u20133150. \n                    https:\/\/doi.org\/10.1002\/art.10623","journal-title":"Arthritis Rheum"},{"key":"727_CR11","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1902\/jop.2008.080233","volume":"79","author":"DL Cochran","year":"2008","unstructured":"Cochran DL (2008) Inflammation and bone loss in periodontal disease. J Periodontol 79:1569\u20131576. \n                    https:\/\/doi.org\/10.1902\/jop.2008.080233","journal-title":"J Periodontol"},{"key":"727_CR12","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1902\/jop.2008.080139","volume":"79","author":"RT Demmer","year":"2008","unstructured":"Demmer RT et al (2008) Transcriptomes in healthy and diseased gingival tissues. J Periodontol 79:2112\u20132124. \n                    https:\/\/doi.org\/10.1902\/jop.2008.080139","journal-title":"J Periodontol"},{"key":"727_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jre.12131","volume":"49","author":"R Fujihara","year":"2014","unstructured":"Fujihara R et al (2014) Tumor necrosis factor-alpha enhances RANKL expression in gingival epithelial cells via protein kinase a signaling. J Periodontal Res 49:508\u2013517. \n                    https:\/\/doi.org\/10.1111\/jre.12131","journal-title":"J Periodontal Res"},{"key":"727_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/00005537-200303000-00009","volume":"113","author":"M Hamzei","year":"2003","unstructured":"Hamzei M et al (2003) Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope 113:436\u2013442. \n                    https:\/\/doi.org\/10.1097\/00005537-200303000-00009","journal-title":"Laryngoscope"},{"key":"727_CR15","doi-asserted-by":"publisher","first-page":"615486","DOI":"10.1155\/2015\/615486","volume":"2015","author":"SA Hienz","year":"2015","unstructured":"Hienz SA, Paliwal S, Ivanovski S (2015) Mechanisms of bone resorption in periodontitis. J Immunol Res 2015:615486. \n                    https:\/\/doi.org\/10.1155\/2015\/615486","journal-title":"J Immunol Res"},{"key":"727_CR16","first-page":"39","volume":"11","author":"CC Huang","year":"1990","unstructured":"Huang CC, Yi ZX, Yuan QG, Abramson M (1990) A morphometric study of the effects of pressure on bone resorption in the middle ear of rats. Am J Otolaryngol 11:39\u201343","journal-title":"Am J Otolaryngol"},{"key":"727_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/000348948309200122","volume":"92","author":"Y Iino","year":"1983","unstructured":"Iino Y, Hoshino E, Tomioka S, Takasaka T, Kaneko Y, Yuasa R (1983) Organic acids and anaerobic microorganisms in the contents of the cholesteatoma sac. Ann Otol Rhinol Laryngol 92:91\u201396. \n                    https:\/\/doi.org\/10.1177\/000348948309200122","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"727_CR18","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1128\/MCB.01028-15","volume":"36","author":"Y Iwamoto","year":"2016","unstructured":"Iwamoto Y et al (2016) Intercellular communication between keratinocytes and fibroblasts induces local osteoclast differentiation: a mechanism underlying cholesteatoma-induced bone destruction. Mol Cell Biol 36:1610\u20131620. \n                    https:\/\/doi.org\/10.1128\/MCB.01028-15","journal-title":"Mol Cell Biol"},{"key":"727_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/01.mlg.0000224345.59291.da","volume":"116","author":"JH Jeong","year":"2006","unstructured":"Jeong JH, Park CW, Tae K, Lee SH, Shin DH, Kim KR, Park YW (2006) Expression of RANKL and OPG in middle ear cholesteatoma tissue. Laryngoscope 116:1180\u20131184. \n                    https:\/\/doi.org\/10.1097\/01.mlg.0000224345.59291.da","journal-title":"Laryngoscope"},{"key":"727_CR20","first-page":"197","volume":"9","author":"TT Jung","year":"1988","unstructured":"Jung TT, Juhn SK (1988) Prostaglandins in human cholesteatoma and granulation tissue. Am J Otolaryngol 9:197\u2013200","journal-title":"Am J Otolaryngol"},{"key":"727_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/00129492-200409000-00003","volume":"25","author":"JY Jung","year":"2004","unstructured":"Jung JY, Pashia ME, Nishimoto SY, Faddis BT, Chole RA (2004) A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma. Otol Neurotol 25:661\u2013668","journal-title":"Otol Neurotol"},{"key":"727_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000481279","volume":"22","author":"T Kamakura","year":"2017","unstructured":"Kamakura T, Nadol JB Jr (2017) Evidence of osteoclastic activity in the human temporal bone. Audiol Neurootol 22:218\u2013225. \n                    https:\/\/doi.org\/10.1159\/000481279","journal-title":"Audiol Neurootol"},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.imlet.2007.03.004","volume":"110","author":"KW Kim","year":"2007","unstructured":"Kim KW et al (2007) Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 110:54\u201364. \n                    https:\/\/doi.org\/10.1016\/j.imlet.2007.03.004","journal-title":"Immunol Lett"},{"key":"727_CR24","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/art.38286","volume":"66","author":"HR Kim","year":"2014","unstructured":"Kim HR, Kim KW, Kim BM, Jung HG, Cho ML, Lee SH (2014) Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis Rheum 66:538\u2013548. \n                    https:\/\/doi.org\/10.1002\/art.38286","journal-title":"Arthritis Rheum"},{"key":"727_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1155\/MI.2005.210","volume":"2005","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Asano K, Kanai K, Suzaki H (2005) Suppressive activity of vitamin D3 on matrix metalloproteinase production from cholesteatoma keratinocytes in vitro. Mediat Inflamm 2005:210\u2013215. \n                    https:\/\/doi.org\/10.1155\/MI.2005.210","journal-title":"Mediat Inflamm"},{"key":"727_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/coa.12332","volume":"40","author":"H Koizumi","year":"2015","unstructured":"Koizumi H, Suzuki H, Ohbuchi T, Kitamura T, Hashida K, Nakamura M (2015) Increased permeability of the epithelium of middle ear cholesteatoma. Clin Otolaryngol 40:106\u2013114. \n                    https:\/\/doi.org\/10.1111\/coa.12332","journal-title":"Clin Otolaryngol"},{"key":"727_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00774-015-0655-5","volume":"34","author":"H Koizumi","year":"2016","unstructured":"Koizumi H, Suzuki H, Ikezaki S, Ohbuchi T, Hashida K, Sakai A (2016) Osteoclasts are not activated in middle ear cholesteatoma. J Bone Miner Metab 34:193\u2013200. \n                    https:\/\/doi.org\/10.1007\/s00774-015-0655-5","journal-title":"J Bone Miner Metab"},{"key":"727_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/00016489.2016.1222549","volume":"137","author":"H Koizumi","year":"2017","unstructured":"Koizumi H et al (2017) Presence of osteoclasts in middle ear cholesteatoma: a study of undecalcified bone sections. Acta Otolaryngol 137:127\u2013130. \n                    https:\/\/doi.org\/10.1080\/00016489.2016.1222549","journal-title":"Acta Otolaryngol"},{"key":"727_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr, Tugendreich S (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30:523\u2013530. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btt703","journal-title":"Bioinformatics"},{"key":"727_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0030-6657(10)70019-6","volume":"64","author":"J Kuczkowski","year":"2010","unstructured":"Kuczkowski J, Kobierska-Gulida G, Izycka-Swieszewska E, Potocka M, Mikaszewski B, Sierszen W (2010) Molecular control of bone resorption in chronic otitis media with cholesteatoma. Otolaryngol Pol 64:219\u2013224. \n                    https:\/\/doi.org\/10.1016\/S0030-6657(10)70019-6","journal-title":"Otolaryngol Pol"},{"key":"727_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000323831","volume":"73","author":"J Kuczkowski","year":"2011","unstructured":"Kuczkowski J, Sakowicz-Burkiewicz M, Izycka-Swieszewska E, Mikaszewski B, Pawelczyk T (2011) Expression of tumor necrosis factor-alpha, interleukin-1alpha, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis ORL. J Otorhinolaryngol Relat Spec 73:93\u201399. \n                    https:\/\/doi.org\/10.1159\/000323831","journal-title":"J Otorhinolaryngol Relat Spec"},{"key":"727_CR32","doi-asserted-by":"publisher","first-page":"854024","DOI":"10.1155\/2015\/854024","volume":"2015","author":"CL Kuo","year":"2015","unstructured":"Kuo CL, Shiao AS, Yung M, Sakagami M, Sudhoff H, Wang CH, Hsu CH, Lien CF (2015) Updates and knowledge gaps in cholesteatoma research. Biomed Res Int 2015:854024\u2013854017. \n                    https:\/\/doi.org\/10.1155\/2015\/854024","journal-title":"Biomed Res Int"},{"key":"727_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00005-015-0373-7","volume":"64","author":"W Likus","year":"2016","unstructured":"Likus W et al (2016) Bacterial infections and osteoclastogenesis regulators in men and women with cholesteatoma arch. Immunol Ther Exp (Warsz) 64:241\u2013247. \n                    https:\/\/doi.org\/10.1007\/s00005-015-0373-7","journal-title":"Immunol Ther Exp (Warsz)"},{"key":"727_CR34","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde D, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN, Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594\u20131602. \n                    https:\/\/doi.org\/10.1056\/NEJM200011303432202","journal-title":"N Engl J Med"},{"key":"727_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429\u2013442. \n                    https:\/\/doi.org\/10.1038\/nri2094","journal-title":"Nat Rev Immunol"},{"key":"727_CR36","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219. \n                    https:\/\/doi.org\/10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"key":"727_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00405-003-0623-x","volume":"261","author":"E Olszewska","year":"2004","unstructured":"Olszewska E, Wagner M, Bernal-Sprekelsen M, Ebmeyer J, Dazert S, Hildmann H, Sudhoff H (2004) Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 261:6\u201324. \n                    https:\/\/doi.org\/10.1007\/s00405-003-0623-x","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"727_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00129492-200309000-00002","volume":"24","author":"FA Peek","year":"2003","unstructured":"Peek FA, Huisman MA, Berckmans RJ, Sturk A, Van Loon J, Grote JJ (2003) Lipopolysaccharide concentration and bone resorption in cholesteatoma. Otol Neurotol 24:709\u2013713","journal-title":"Otol Neurotol"},{"key":"727_CR39","doi-asserted-by":"publisher","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","volume":"285","author":"LJ Raggatt","year":"2010","unstructured":"Raggatt LJ, Partridge NC (2010) Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285:25103\u201325108. \n                    https:\/\/doi.org\/10.1074\/jbc.R109.041087","journal-title":"J Biol Chem"},{"key":"727_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/jcp.47.6.529","volume":"47","author":"MT Rehman","year":"1994","unstructured":"Rehman MT, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47:529\u2013534","journal-title":"J Clin Pathol"},{"key":"727_CR41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/jci200316069","volume":"111","author":"CT Ritchlin","year":"2003","unstructured":"Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM (2003) Mechanisms of TNF-\u03b1\u2013 and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Investig 111:821\u2013831. \n                    https:\/\/doi.org\/10.1172\/jci200316069","journal-title":"J Clin Investig"},{"key":"727_CR42","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673\u20132682. \n                    https:\/\/doi.org\/10.1084\/jem.20061775","journal-title":"J Exp Med"},{"key":"727_CR43","doi-asserted-by":"publisher","first-page":"16683","DOI":"10.1038\/srep16683","volume":"5","author":"Y Si","year":"2015","unstructured":"Si Y et al (2015) TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction. Sci Rep 5:16683. \n                    https:\/\/doi.org\/10.1038\/srep16683","journal-title":"Sci Rep"},{"key":"727_CR44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292\u2013304. \n                    https:\/\/doi.org\/10.1038\/nri2062","journal-title":"Nat Rev Immunol"},{"key":"727_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::Aid-Anr4>3.0.Co;2-W","volume":"43","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H et al (2000) Involvement of receptor activator of nuclear factor kappa B ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43:259\u2013269. \n                    https:\/\/doi.org\/10.1002\/1529-0131(200002)43:2<259::Aid-Anr4>3.0.Co;2-W","journal-title":"Arthritis Rheum"},{"key":"727_CR46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"SL Teitelbaum","year":"2003","unstructured":"Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638\u2013649. \n                    https:\/\/doi.org\/10.1038\/nrg1122","journal-title":"Nat Rev Genet"},{"key":"727_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000346140","volume":"18","author":"J Tomlin","year":"2013","unstructured":"Tomlin J, Chang D, McCutcheon B, Harris J (2013) Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurootol 18:135\u2013142. \n                    https:\/\/doi.org\/10.1159\/000346140","journal-title":"Audiol Neurootol"},{"key":"727_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/000348949510400609","volume":"104","author":"Y Uno","year":"1995","unstructured":"Uno Y, Saito R (1995) Bone resorption in human cholesteatoma: morphological study with scanning electron microscopy. Ann Otol Rhinol Laryngol 104:463\u2013468. \n                    https:\/\/doi.org\/10.1177\/000348949510400609","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"727_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1808-8694(15)31133-2","volume":"73","author":"RF Vitale","year":"2007","unstructured":"Vitale RF, Ribeiro Fde A (2007) The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma. Braz J Otorhinolaryngol 73:117\u2013121. \n                    https:\/\/doi.org\/10.1016\/S1808-8694(15)31133-2","journal-title":"Braz J Otorhinolaryngol"},{"key":"727_CR50","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/lary.25834","volume":"126","author":"S Xie","year":"2016","unstructured":"Xie S, Xiang Y, Wang X, Ren H, Yin T, Ren J, Liu W (2016) Acquired cholesteatoma epithelial hyperproliferation: roles of cell proliferation signal pathways. Laryngoscope 126:1923\u20131930. \n                    https:\/\/doi.org\/10.1002\/lary.25834","journal-title":"Laryngoscope"},{"key":"727_CR51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/00129492-200209000-00007","volume":"23","author":"S Yetiser","year":"2002","unstructured":"Yetiser S, Satar B, Aydin N (2002) Expression of epidermal growth factor, tumor necrosis factor-\u03b1, and interleukin-1\u03b1 in chronic otitis media with or without cholesteatoma. Otol Neurotol 23:647\u2013652. \n                    https:\/\/doi.org\/10.1097\/00129492-200209000-00007","journal-title":"Otol Neurotol"}],"container-title":["Journal of the Association for Research in Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10162-019-00727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10162-019-00727-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10162-019-00727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T02:34:29Z","timestamp":1593225269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10162-019-00727-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1007\/s10162-019-00727-1","relation":{},"ISSN":["1525-3961","1438-7573"],"issn-type":[{"value":"1525-3961","type":"print"},{"value":"1438-7573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"3 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}